ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Two-Drug combo slow genetic Alzheimer's?
Disease control OngoingThis study tests whether a new drug (E2814) combined with lecanemab can slow the progression of Alzheimer's in people who have a genetic mutation that causes the disease. About 197 adults aged 18-80 with mild symptoms or no symptoms will receive either the drug combo or a placebo…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 29, 2026 04:00 UTC
-
Blood test may cut time to Alzheimer's diagnosis, study says
Knowledge-focused TerminatedThis study aimed to see if using a blood test (PrecivityAD2) early helps doctors diagnose Alzheimer's disease faster. Participants with memory problems were to be split into two groups: one getting the blood test results right away, the other getting them later. The study was wit…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: C2N Diagnostics • Aim: Knowledge-focused
Last updated Apr 29, 2026 03:58 UTC